Evidence map›Paper›PMID 36836187›Full record

ArticleJournal of clinical medicine2023

Serial Non-Invasive Myocardial Work Measurements for Patient Risk Stratification and Early Detection of Cancer Therapeutics-Related Cardiac Dysfunction in Breast Cancer Patients: A Single-Centre Observational Study.

Ana Moya, Dimitri Buytaert, Monika Beles, Pasquale Paolisso, Jürgen Duchenne, Greet Huygh, Ciska Langmans, Adelheid Roelstraete, Sofie Verstreken, Marc Goethals and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Long-term subclinical cardiac damage in people living with human immunodeficiency virus.International journal of cardiology. Heart & vasculature · 2026
    Article
  2. Review
  3. How to Use Multimodality Imaging in Cardio-Oncology.Journal of cardiovascular development and disease · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Ana MoyaCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.ORCID 0000-0003-3249-8627
Dimitri BuytaertCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Monika BelesCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Pasquale PaolissoCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.ORCID 0000-0002-7017-778X
Jürgen DuchenneDepartment of Cardiovascular Sciences, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.
Greet HuyghDepartment of Oncology and Radiotherapy, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Ciska LangmansDepartment of Oncology and Radiotherapy, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Adelheid RoelstraeteDepartment of Oncology and Radiotherapy, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Sofie VerstrekenCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Marc GoethalsCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Riet DierckxCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Jozef BartunekCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.ORCID 0000-0002-4927-1632
Martin PenickaCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Guy Van CampCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.ORCID 0000-0002-9815-8337
Ward A HeggermontCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Marc VanderheydenCardiovascular Research Center, OLV Hospital, Moorselbaan 164, B-9300 Aalst, Belgium.
Onze Lieve Vrouwziekenhuis Hospital · BEKU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serial transthoracic echocardiographic (TTE) assessment of LVEF and GLS are the gold standard in screening Cancer Therapeutics-Related Cardiac Dysfunction (CTRCD). Non-invasive left-ventricle (LV) pressure-strain loop (PSL) emerged as a novel method to quantify Myocardial Work (MW). This study aims to describe the temporal changes and longitudinal trajectories of MW indices during cardiotoxic treatment. We included 50 breast cancer patients with normal LV function referred for anthracycline therapy w/wo Trastuzumab. Medical therapy, clinical and echocardiographic data were recorded before and 3, 6, and 12 months after initiation of the chemotherapy. MW indices were calculated through PSL analysis. According to ESC guidelines, mild and moderated CTRCD was detected in 10 and 9 patients, respectively (20% CTRCD

Indexed as

anthracyclinesCancer Therapeutics-Related Cardiac DysfunctioncardiotoxicityMyocardial Workpressure–strain loopsspeckle tracking

Identifiers

PMID36836187
PMCPMC9964877
OpenAlexW4321377939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.